u/Soft_Ant4357 · 345d agono track record yet
“holding a small position with a $.30 average”
PSCA - A Biopharmaceutical - The Next Runner?
Processa Pharmaceuticals is a small-cap biopharmaceutical with pipeline catalysts in 2025-2026, including Phase 2/3 NGC-Gemcitabine trials, FDA discussions on PCS499, and investor conferences. The company has sufficient cash runway (7-9 months) to reach key milestones without near-term dilution threats, positioning it as a potential runner for early-stage biotech investors.
Now $1.9525m ago